Fabrice N. Vincent

Top rated Personal Injury attorney in San Francisco, California

Lieff Cabraser Heimann & Bernstein, LLP
Fabrice N. Vincent
Lieff Cabraser Heimann & Bernstein, LLP

Practice Areas: Personal Injury, Class Action & Mass Torts, Environmental

Licensed in California since: 1992

Education: Cornell University Law School

Selected to Super Lawyers: 2006 - 2024

Lieff Cabraser Heimann & Bernstein, LLP

275 Battery Street
29th Floor
San Francisco, CA 94111 Phone: 415-956-1000 Email: Fabrice N. Vincent Visit website


A partner in our San Francisco office, Fabrice N. Vincent is a tireless and principled advocate for the injured and the families of loved ones who died in personal injury and wrongful death cases. Fabrice’s cases include JUUL vaping injury claims, baby formula injury and death claimshair relaxer cancer claims, aviation accidents, auto and recreational vehicle accidents, cases arising from defective infant and consumer products, dangerous prescription drugs, and faulty medical devices.

Fabrice’s practice also includes cases involving environmental toxic exposures, medical malpractice, and international and human rights violations. In many of the cases Fabrice has prosecuted, he has assisted our clients in persuading corporate defendants to issue recalls or improve their safety procedures for the protection of all consumers and patients.

Fabrice played a pivotal role in the firm’s representation of patients injured by the diet drugs fenfluramine (sold as Pondimin) and dexfenfluramine (sold as Redux), which resulted in a $4.75 billion settlement for those who developed cardiac valve damage or the often fatal condition of Primary Pulmonary Hypertension after taking Pondimin or Redux. Fabrice successfully represented scores of injured patients in individual lawsuits. Fabrice has been recognized by Super Lawyers magazine as a Northern California Super and has written extensively on current issues in litigation.

First Admitted: 1992, California

Professional Webpage: http://www.lieffcabraser.com/Attorneys/Fabrice-N-Vincent.sht...

  • Selected for inclusion by peers in The Best Lawyers in America in fields of “Mass Tort Litigation/Class Actions – Plaintiffs,” “Product Liability Litigation – Plaintiffs” and “Personal Injury Litigation – Plaintiffs,” 2012 – 2024; “Lawdragon 500 Leading Plaintiff Consumer Lawyers in America,” Lawdragon, 2023, 2024; “Super Lawyer for Northern California,” Super Lawyers, 2006-2023;  “Outstanding Subcommittee Chair for the Class Actions & Derivative Suits,” ABA Section of Litigation, 2013, Lieff Cabraser Heimann & Bernstein
Bar/Professional Activity:
  • American Association for Justice American Bar Association, Book Committee, Member, 2022 American Bar Association, Co-Chair, Business Torts & Unfair Competition Committee, 2022-2023 American Bar Association, Co-Chair, Products Liability Committee, 2019;  American Bar Association, Co-Chair, Class Actions Committee, 2017, 2018;  Association of Business Trial Lawyers;  Bar Association of San Francisco;  Fight for Justice Campaign;  Society of Automotive Engineers;  State Bar of California
Educational Background:
  • University of California, Berkeley, California, B.A. – 1989
Scholarly Lectures/Writings:
  • Fabrice also contributes to Google+ and the Lieff Cabraser civil justice blog.
  • Co-Editor in Chief, “ABA Survey of Federal Class Action Law,” 2018-present
  • Author, "Special Master Rules Against SmithKline Beecham Privilege Log" (November 1999)
  • Co-Author, "How Class Proofs of Claim in Bankruptcy Can Help in Medical Monitoring Cases" (Leader Publications 1999)
  • Co-Author, "Class Certification of Medical Monitoring Claims in Mass Tort Product Liability Litigation" (ALI-ABA Course of Study 1999)
  • Co-Author, "The Future of Prescription Drug Products Liability Litigation in a Changing Marketplace" and "Six Courts Certify Medical Monitoring Claims for Class Treatment," 29 Forum 4 (Consumer Attorneys of California 1999)
  • Author, "Off-Label Drug Promotion Permitted" (Oct. 1999)
  • Co-Editor-In-Chief, Fen-Phen Litigation Strategist (Leader Publications 1998-2000)
  • Co-Author, "With Final Approval, Diet Drug Class Action Settlement Avoids Problems That Doomed Asbestos Pact" (Leader Publications 2000)
  • Co-Author, Introduction, "Sanctioning Discovery Abuses in the Federal Court" (LRP Publications 2000)
  • Author, "AHP Loses Key California Motion In Limine" (February 2000)
  • Co-Author, "The Shareholder Strikes Back: Varied Approaches to Civil Litigation Claims Are Available to Help Make Shareholders Whole," Mealey's Emerging Securities Litigation Reporter (September 2002)
  • Co-Author, "Ethics and Admissibility: Failure to Disclose Conflicts of Interest in and/or Funding of Scientific Studies and/or Data May Warrant Evidentiary Exclusions," Mealey's December Emerging Drugs Reporter (December 2002)
  • Co-Author, with Elizabeth J. Cabraser, "Class Actions Fairness Act of 2005," California Litigation, Vol. 18, No. 3 (2005)
  • Co-Editor, California Class Actions Practice and Procedures (2003-06)
  • Coordinating Editor and Co-Author, California section of the ABA State Class Action Survey (2001-14)
  • Executive Editor and Co-Author, "Decisions Interpreting California's Rules of Class Action Procedure," Survey of State Class Action Law (ABA 2000-present), updated and re-published in 5 Newberg on Class Actions (2001-present)
  • Lead Author, Citizen Report on Utility Terrain Vehicle (UTV) Hazards and Urgent Need to Improve Safety and Performance Standards; and Request for Urgent Efforts To Increase Yamaha Rhino Safety and Avoid Needless New Catastrophic Injuries, Amputations and Deaths, Lieff Cabraser Heimann & Bernstein, LLP (2009)

Office location for Fabrice N. Vincent

275 Battery Street
29th Floor
San Francisco, CA 94111


19 Years Super Lawyers
  • Super Lawyers: 2006 - 2024

Attorney resources for Fabrice N. Vincent

Page Generated: 0.059139013290405 sec